Literature DB >> 1355484

Expression of intercellular adhesion molecule 1 (ICAM-1) during the development of invasion and/or metastasis of gastric carcinoma.

S Koyama1, T Ebihara, K Fukao.   

Abstract

In this study, using two-color flow-cytometric analysis, we examined the expression of histocompatibility locus antigens (HLA) classes I and II, and intercellular adhesion molecule 1 (ICAM-1) in 10 cases of normal gastric mucosa, 13 cases of primary carcinoma on the stomach, 16 cases of metastatic carcinoma from malignant ascites in patients with gastric carcinoma and 14 samples of their cultured carcinoma cells. Compared with normal gastric mucosa, HLA class I were highly expressed in a considerable number of tumor cells in each experimental group. The expression of HLA class II tended to reduce in the order of normal gastric mucosa, primary gastric carcinoma and peritoneal-effusion-associated carcinoma. Altogether, 85.7% of cases of cultured tumor cells showed abrogation and loss of HLA class II. The ICAM-1 molecule was not detected on normal gastric epithelial cells. In few cases, carcinoma cells from large volumes of tumor located in the stomach showed detectable amounts of ICAM-1. On the other hand, all of the metastatic carcinoma cells from peritoneal effusions showed a high level of expression of the ICAM-1 molecule. The expression of ICAM-1 on adenocarcinoma cells was maintained and/or augmented by in vitro cultivation with tumor-infiltrating lymphocytes (TIL). Furthermore, two-color fluorescence-activated cell sorting analysis of TIL revealed that significant correlation was observed between the expression of ICAM-1 and the degree of TIL, composed mainly of CD3+ T cells including CD8+CD11b-, CD8+CD28+, CD8+S6F1+ and CD4+Leu8+, and CD57+CD16- and CD57+CD16+ NK cells, and HLA-DR+LeuM3+ macrophages.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1355484     DOI: 10.1007/bf01211806

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  42 in total

1.  A monoclonal antibody against altered LFA-1 induces proliferation and lymphokine release of cloned T cells.

Authors:  H Pircher; P Groscurth; S Baumhütter; M Aguet; R M Zinkernagel; H Hengartner
Journal:  Eur J Immunol       Date:  1986-02       Impact factor: 5.532

2.  Differences in surface phenotype and mechanism of action between alloantigen-specific CD8+ cytotoxic and suppressor T cell clones.

Authors:  J Koide; E G Engleman
Journal:  J Immunol       Date:  1990-01-01       Impact factor: 5.422

3.  Recognition of pre-processed endogenous antigen by class I but not class II MHC-restricted T cells.

Authors:  M T Sweetser; L A Morrison; V L Braciale; T J Braciale
Journal:  Nature       Date:  1989-11-09       Impact factor: 49.962

4.  Alloantigen recognition is preceded by nonspecific adhesion of cytotoxic T cells and target cells.

Authors:  H Spits; W van Schooten; H Keizer; G van Seventer; M van de Rijn; C Terhorst; J E de Vries
Journal:  Science       Date:  1986-04-18       Impact factor: 47.728

5.  Cell-cell adhesion mediated by CD8 and MHC class I molecules.

Authors:  A M Norment; R D Salter; P Parham; V H Engelhard; D R Littman
Journal:  Nature       Date:  1988-11-03       Impact factor: 49.962

6.  A role of Ia-associated invariant chains in antigen processing and presentation.

Authors:  B Stockinger; U Pessara; R H Lin; J Habicht; M Grez; N Koch
Journal:  Cell       Date:  1989-02-24       Impact factor: 41.582

7.  Characterization of human lymphocyte subpopulations: alloreactive cytotoxic T-lymphocyte precursor and effector cells are phenotypically distinct from Leu 2+ suppressor cells.

Authors:  L T Clement; M K Dagg; A Landay
Journal:  J Clin Immunol       Date:  1984-09       Impact factor: 8.317

8.  Clonal analysis of human cytotoxic T lymphocytes: T4+ and T8+ effector T cells recognize products of different major histocompatibility complex regions.

Authors:  S C Meuer; S F Schlossman; E L Reinherz
Journal:  Proc Natl Acad Sci U S A       Date:  1982-07       Impact factor: 11.205

9.  Purified intercellular adhesion molecule-1 (ICAM-1) is a ligand for lymphocyte function-associated antigen 1 (LFA-1).

Authors:  S D Marlin; T A Springer
Journal:  Cell       Date:  1987-12-04       Impact factor: 41.582

10.  Differential activation of lymphokine-activated killer cells with different surface phenotypes by cultivation with recombinant interleukin 2 or T-cell growth factor in gastric cancer patients.

Authors:  S Koyama; T Ebihara; K Fukao; T Osuga
Journal:  Jpn J Cancer Res       Date:  1989-02
View more
  28 in total

1.  Immunohistochemical analysis of intercellular adhesion molecule-1 expression in human gastric adenoma and adenocarcinoma.

Authors:  R Nasu; M Mizuno; T Kiso; K Shimo; T Uesu; J Nasu; J Tomoda; H Okada; T Tsuji
Journal:  Virchows Arch       Date:  1997-04       Impact factor: 4.064

2.  Down regulation of endothelial adhesion molecules in node positive breast cancer: possible failure of host defence mechanism.

Authors:  Maya Madhavan; Priya Srinivas; Elizabeth Abraham; Iqbal Ahmed; N R Vijayalekshmi; Prabha Balaram
Journal:  Pathol Oncol Res       Date:  2002       Impact factor: 3.201

3.  CD54 expression is predictive for lymphatic spread in human gastric carcinoma.

Authors:  Masakazu Yashiro; Takeshi Sunami; Kosei Hirakawa
Journal:  Dig Dis Sci       Date:  2005-12       Impact factor: 3.199

Review 4.  Circulating soluble intercellular adhesion molecule-1 in lung cancer: a systematic review.

Authors:  Xiaoling Gu; Chunyan Ma; Dongmei Yuan; Yong Song
Journal:  Transl Lung Cancer Res       Date:  2012-03

5.  Differential expression of alternatively spliced transcripts related to energy metabolism in colorectal cancer.

Authors:  Anastasiya Vladimirovna Snezhkina; George Sergeevich Krasnov; Andrew Rostislavovich Zaretsky; Alex Zhavoronkov; Kirill Mikhailovich Nyushko; Alexey Alexandrovich Moskalev; Irina Yurievna Karpova; Anastasiya Isaevna Afremova; Anastasiya Valerievna Lipatova; Dmitriy Vladimitovich Kochetkov; Maria Sergeena Fedorova; Nadezhda Nikolaevna Volchenko; Asiya Fayazovna Sadritdinova; Nataliya Vladimirovna Melnikova; Dmitry Vladimirovich Sidorov; Anatoly Yurievich Popov; Dmitry Valerievich Kalinin; Andrey Dmitrievich Kaprin; Boris Yakovlevich Alekseev; Alexey Alexandrovich Dmitriev; Anna Viktorovna Kudryavtseva
Journal:  BMC Genomics       Date:  2016-12-28       Impact factor: 3.969

6.  New cell lines of gastric and pancreatic cancer: distinct morphology, growth characteristics, expression of epithelial and immunoregulatory antigens.

Authors:  M Heike; O Röhrig; H E Gabbert; R Moll; K H Meyer zum Büschenfelde; W G Dippold; A Knuth
Journal:  Virchows Arch       Date:  1995       Impact factor: 4.064

Review 7.  New insights into tumor-host interactions in lymphoma metastasis.

Authors:  V Umansky; V Schirrmacher; M Rocha
Journal:  J Mol Med (Berl)       Date:  1996-07       Impact factor: 4.599

8.  Venous tumor thrombosis and cavernous transformation of the portal vein in a patient with gastric carcinoma.

Authors:  M Ishikawa; S Koyama; T Ikegami; H Fukutomi; T Gohongi; K Yuzawa; K Fukao; M Fujiwara; K Fujii
Journal:  J Gastroenterol       Date:  1995-08       Impact factor: 7.527

9.  Origin of CD57+ T cells which increase at tumour sites in patients with colorectal cancer.

Authors:  T Okada; T Iiai; Y Kawachi; T Moroda; Y Takii; K Hatakeyama; T Abo
Journal:  Clin Exp Immunol       Date:  1995-10       Impact factor: 4.330

10.  Prognostic value of CD57(+) T lymphocytes in the peripheral blood of patients with advanced gastric cancer.

Authors:  Junji Akagi; Hideo Baba
Journal:  Int J Clin Oncol       Date:  2008-12-18       Impact factor: 3.402

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.